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Abstract 
Background: Autophagy suppression recently has been known to have a remarkable effect for cellular adjustment 
and viability in the final stages of cancer. On the other hand, autophagy has the potential effect in preventing many 
viruses from replication. Beclin1 is the most substantial constituent in autophagy apparatus regulation. This study 
was intended to investigate the beclin1 siRNA knockdown effect on the extent of activity of the oncolytic vesicular 
stomatitis virus (VSV) as a model in cell culture. Materials and Methods: In the current study, the cancer cell line , 
HeLa (cervical squamous cancer cell line ) was infected by VSV, followed by beclin1 siRNA vector transfection. 
The potential change in the expressions of gene beclin1 in transfected cells, as well as untransfected ones were 
examined by real time PCR, and also the titer of viruses was compared in cells with and without transfection. 
Results: The results revealed that the amount of putative gene beclin1 expression in HeLa cells decreased greatly 
due to siRNA suppressive impact, and also the sensitivity of the cells to VSV oncolytic effect increased upon 
decrease in beclin1gene expression. Conclusion: It seems that autophagy suppression by using siRNA with VSV is 
a substantial aid for increase in virus titer in cancer cell lines.  
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Autophagy machine has been suggested to act 
as a cell surviving constituent. It functions to 
maintain cellular homeostasis in conditions such as 
nutrient deprivation and micro environmental 
pressures (1, 2). Though, autophagy provides 
eukaryotic cells the required energy by recycling 
DNA and RNA material, Protein aggregates, as well 
as cellular organelles, thus promoting persistence of 
established malignancies (3, 4).  
From the molecular point of view, autophagy 
is governed by a pannel of genes, particularly ones 
encoding yeast Atg- related proteins. The most 
substantial protein coding gene in this category is 
Beclin-1(mammalian homologue of Atg6). It is a gene 
encodes for a protein, which has a major role in 
coordinating autophagy machine operation. Beclin1 
interferences with Ambra1, BIF1, UVRAG proteins 
promote autophagy and with Bcl2, and Rubicon. Also, 
its interaction with Vps34 (PI3KIII) creates the two-
layer membrane of autophagosom (5).  
Remarkably, autophagy is active in fighting 
against viruses. Autophagy activation in virus infected 
cells leads to form the two layer membrane vesicles, 
consequently  getting rid of virulent invaders. Also, it 
functions as an innate and adaptive immune response 
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trigger to fight against viruses. Excluding some 
viruses like HCV and other flaviviruses that take 
advantage of autophagy in favor of their replication, 
reducing the autophagy can help the viruses in 
infected cells to propagate more efficiently and cause 
more oncolytic effects in cells. This can be taken as a 
strategy to increase virus titer in producing cells and 
also to augment the efficacy of oncolytic viruses in 
cancer cell therapy (3, 6-8).  
Many viruses are striking examples of major 
public health concerns in modern era. They create 
health problems for millions of people throughout the 
world every year, such as severe infections, 
neoplasm, etc (9). Vaccination for such infections is 
one of the main ways to control the disorders which 
demand high production of attenuated viruses in 
vaccine producing companies. 
On the other hand, in contrast to the fact that 
some malignancies like hepato cellular carcinoma, 
burkit lymphoma and cervical carcinoma induce by 
viruses; oncolytic viruses could have anti-mitotic 
qualities and cell destruction activity which are 
desired in fighting against cancer.  Moreover, 
Medical advances in cancer therapy have developed 
a set of therapeutic option including chemotherapy, 
surgery interferences, immunotherapy, radiotherapy 
and so on. However, challenging complications for 
sick people facing severe side effects of mentioned 
therapies has prompted medical scientists to look for 
more safe potential cure options. Therefore, viruses 
have gained remarkable attention in treatment of 
several cancers due to their good spread in malignant 
cells the low side effects for patients (10, 11).  
VSV is one of the oncolytic viruses which 
have attracted many attentions in the field of cancer 
virotherapy. It has been shown that in VSV sensitive 
cancer cells, the expression of Beclin1 has reduced in 
comparison with VSV resistance tumor cells (12). 
In the present study, we aimed on evaluating 
relation between autophagy knockdown and the rate 
of VSV replication in a suitable cervical cancer 
model (HeLa cells).  
Methods 
Plasmid preparation and siRNA ligation. 
The vector used in this study was a pCDH3.0. 
Beclin-1 siRNA was designed with sticky ends 
compatible to BamH1 and EcoR1at 5´ and 3´ends, 
respectively and synthesized by Tag Copenhagen 
company (Denmark) in shRNA formulation. That 
targets from position of 584nt to 608nt of Beclin 1 
mRNA.  
 The siRNA ligation reaction to the pCDH3.0 
plasmid vector was accomplished, based on T4 ligase 
action on BamH1 and EcoR1 at the linearized plasmid 
ends. Clony PCR was performed by universal primers 
to amplify the ligated siRNA, after propagating the 
vector in Escherichia coli DH5α medium culture. 
Then, PCR product was undergone running on 2% 
agarose gel including Red green dye, followed by a 
digital CCD camera picture taken of the gel to 
documentation. Also, PCR product was subjected to 
Sanger sequencing in ABI sequencer 3130 equipment, 
using universal primers.   
Transfection of HeLa cell. After culturing 
HeLa cells (cancer cells from cervical tumor), 5% fetal 
bovine DMEM (Gibco,UK) medium- antibiotic free- 
was aliquoted to every single well of a 24-well plate. 
The process followed 24 hrs by adding the contents of 
two transfection reagent solution, one containing 
(lipofectamine 2000, invitrogen, pCDH vector and 
free-serum medium) and the other same but containing 
mock siRNA were added drop-wise in different 
concentrations in to the wells. Then, treated medium 
cultures were incubated for 72 hrs in 37˚C, 10% CO2. 
Transfected cells were examined by fluorescent invert 
microscopy, and the presence of GFP gene expression 
on the penetrated plasmid was identified for cell 
transfection.  
RNA extraction & cDNA preparation. HeLa 
cell cultures in 96-well plate were kept in 5% CO2 
incubator in 37˚C for 24 hours till they were subjected 
to either siRNA transfection or mock vector 
transfection in separate rows, while leaving one row 
intact as control. HeLa cells, corresponding to each 
well, were harvested after 48 hours of incubation in 
37˚C by shoveling well bottoms up before micro tube 
centrifugation. Next, using the high quality RNA 
extraction kit (Roche, Basel, Switzerland),total RNAs 
of precipitated cells were extracted. RT- PCR reaction 
was performed to synthesize beclin-1 complementary 
DNA for each sample tube using cDNA synthesis 
kit (Qiagen, Hilden, Germany), which included 
hexamer primers. 
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Real –time PCR reaction. The rate of beclin 
1 expression in siRNA and mock transfected cells 
were evaluated by ABI realtime instrument using 
Taq Man assay (Qiagen, Hilden, Germany), based on 
comparison with GAPDH gene as base level of 
mRNA. Data analysis was done by REST program 
with respect to realtime PCR output .  
Cell Culture and Virus Titer Determination 
via TCID50. HeLa cells were used to propagate VSV 





) of the virus were inoculated on HeLa cells in 
a 96-well culture plate, with being one row 
uninoculated as control. After 72 hour the 
microplates were examined for CPE and the Karber 
formula was exploited to calculate virus titer.  
The same procedure was performed with 
putative cells, transfected with siRNA 24 hrs before 
virus inoculation. Both of the experiments were 
performed in triplicates.  
Results 
Construction of siRNA-pCDH vector. 
Beclin1 siRNA fragment with two sticky ends was 
inserted in to a pCDH plasmid in MCS under the 
control of a CMV promoter, so this vector can 
express the gene of interest in mammalian cells. 
Incorporated SV40 origin can ease replication in 
human cell lines and an ori, elsewhere, replication in 
prokaryotes. The designed siRNA included a 
potential loop motif sequence, intended to function as 
a site for cleaving function of nuclear enzyme, 
Dorsha (Rnasen), and sense and anti-sense strands, 
which are corresponding to coding regions on 
beclin1 mRNA transcripts.  
The results obtained by colony PCR in 
screening for recombinant plasmids, included siRNA 
fragment, confirmed the ligation procedure accuracy. 
Illustration of PCR products run on gel electrophoresis 
was given (Fig1) .   
Real-time PCR. Quantitative PCR assay for 
beclin1 gene expression 72 hrs after siRNA 
suppression was performed. Melting point curve was 
verified for PCR accuracy (Fig 2). CT values for real-
time PCR reactions were determined regarding to 
amplification plots. Beclin1 gene expression for 
siRNA treated cells in comparison to untreated cells 
showed a great decrease of 1000 time fold (p<0.0001), 
as evaluated by REST program analyzer. 
 Virus titration in HeLa cells. To estimate and 
compare titer of VSV in the presence and absence of 
Beclin 1expression, 72 hours after virus inoculation 
VSV titer was calculated. The survey presented 10
8.66 
TCID50/ml for VSV in HeLa cell and 10
10.59 
TCID50/ml in siRNA transfected cells. 
Discussion 
Cancer treatment has attracted many researches 
in the new world. Due to its complicated nature, many 
approaches in experimental studies have been 
exploited to pickup new path for more efficient cure, 
including attempting various signaling pathways 
which may confer new strategies for gene therapies.  
Autophagy is a cellular mechanism for 
maintaining homeostasis. It plays an important role in 
preventing cellular events due to environmental 
pressures from progression to dysplastic changes. 
However, autophagy machine in established malignant 
cells is out to compensate for nutrients shortage and 
genome instability to lengthen survival time(13).  
Several previous studies showed a positive 
effect of autophagy knockdown in ameliorating 
malignancy phase in different types of cancers. 
Accordingly, results obtained by the current study 
presented strong effect of beclin1 siRNA in silencing 
autophagy response (14-16).  
On the other hand, autophagy reduction can 
help many viruses to replicate more efficiently. Data 
obtained from previous studies showed VSV 
immediately activates autophagy formation upon its 
surface glycoprotein attach, called VSVG. The 
activated autophagy controls VSV replication (6).  
 
Figure 1. PCR cloning products run on 2% agarose gel 
electrophoresis to confirm the ligation process, using universal 
primers. The lane 7 represents  a ligated plasmid pCDH, compared 
with the other lanes showing unligated plasmids.  
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Because of the defect in innate immunity in 
tumor cells, many transformed cells are sensitive to 
viral replication. This is the base of using some 
viruses as oncolytic agents. Since autophagy is a part 
of innate immune response, depriving from 
autophagy machine could be a good device to 
facilitate viral trafficking in to such cancerous cells. 
This suggests autophagy can benefit new strategies 
of viral therapy for cancer. A remarkable number of 
studies have showed autophagy blocking drugs such 
as 3MA (PI3KIII inhibitor) is effective in sensitizing 
cancer cells in treatment approaches like hormon , 
radiotherapy etc. In the context of inhibiting 
autophagy viruses can evade from being trapped in 
cellular xenophagy, hence protecting themselves to 
replicate more efficiently in cancerous cells (3, 6, 13, 
17, 18).  
The current study was to evaluate autophagy 
suppression through beclin1gene knockdown in a 
scenario where VSV would reproduce more 
vigorously. As notified, beclin1 gene silencing could 
have a substantial effect on increasing titer of the 
virus in HeLa cells. This confers autophagy 
suppression in combination with VSV can be 
influential in cervical squamous cell therapy.  
Besides, this data from VSV as a model virus 
can be applied to increase the rate of virus replication 
and production of virus particles in cell culture.  
Finally, gene therapy in combination with 
virotherapy have shown appropriate results in the cell 
line level (19, 20). It is suggested that the future 
studies address the effects of this combinatorial 
therapy in proper animal models (21). On the other 
hand, reducing autophagy in cells can be considered as 
a benefit approach to increase the titer of many viruses 
when high titer of virus production is desired.  
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